期刊文献+

壳聚糖包裹紫杉醇纳米粒子的制备及性能研究 被引量:2

Preparation of Paclitaxel-loaded chitosan nanoparticles and its physicochemical characterization
下载PDF
导出
摘要 目的探讨壳聚糖-紫杉醇纳米粒子(CS-PTX-NP)的制备方法并研究其特性。方法采用溶剂挥发-乳化交联法制备壳聚糖-紫杉醇载药纳米粒子,借助红外光谱仪分析粒子结构,使用透射电子显微镜检测粒子的形态、粒径及分布,紫外分光光度计测定载药量和包封率,并考察粒子的体外释放性能,探讨影响制备该粒子的主要因素。结果粒子的平均粒径为(116±3.07)nm,成球性、分散性好,粒子的包封率最大可达94.04%,主要受Mptx∶Mcs、搅拌速度的影响。粒子在生理条件下具有明显的缓释作用。结论壳聚糖紫杉醇纳米粒子的制备为开发脂溶性药物缓释制剂提供了一条新的途径。 Objective To Prepare chitosan-paclitaxel nanoparticles and study their characteristics.Methods Taxol and Chitosan-loaded nanoparticles were prepared by solvent evaporation and emulsion cross-linking.The structure of particles was analyzed by infrared spectroscopy;and the size,morphology and distribution of particles were examined by transmission electron microscope.Finally the drug-loading and encapsulation rate as well as its in vitro release characteristics were all analyzed by UV-spectrophotometer.Results The average diameter of nanoparticles was 116±3.07nm with good encapsulation efficiency up to 94.04% which were mainly influenced by mptx/mcs ratio and the stirring speed.Sustained release under physiological conditions was observed in these particles.Conclusion Nanoparticles containing paclitaxel shelled with chitosan may provide a new approach for the development of fat-soluble drug delivery.
出处 《同济大学学报(医学版)》 CAS 2010年第5期36-41,共6页 Journal of Tongji University(Medical Science)
基金 上海市科委资助项目(074119647) 上海市卫生局资助项目(2007147)
关键词 紫杉醇 壳聚糖 缓释作用 paclitaxel chitosan release effect
  • 相关文献

参考文献14

二级参考文献101

  • 1施水萍,冯年平,武培怡.聚酯型高分子纳米载药系统研究进展[J].中国现代应用药学,2005,22(3):205-209. 被引量:7
  • 2李文俊.-[J].高分子学报,1997,2:106-110.
  • 3Smith JP, Stock E, Orenberg EK, et al. Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts [J]. Anticancer Drugs, 1995,6(6) :717-726.
  • 4Hussain M, Beale G, Hughes M, et al. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-coglycolide) microsphere formulations for potential combination therapy in cancer [J]. IntJ Pharm, 2002,234 (1-2):129-138.
  • 5Nagaich S, Khopade AJ, Jain NK.Lipid grafts of egg-box complex: a new supramolecular biovector for 5 -fluorouracil delivery [J]. Pharm Acta Helv, 1999,73: 227-236.
  • 6Kwon GS, Okano T. Polymeric micelles as new drug carriers [J]. Adv Drug Deliv Rev, 1996, 21:107-116.
  • 7Tobio M, Gref R, Sanchez A, et al.Stealth PLA-PEG nanoparticles as protein carriers for nasal administration [J]. Pharm Res, 1998,15 (2):270-275.
  • 8Zhang Y, Zhang QH, Zha LS, et al.Preparation, characterization and application of pyrene-loaded methoxy poly(ethylene glycol)-poly(lactic acid)opolymer nanoparticles [J]. Colloid Polym Sci, 2004,282 (12): 1323-1328.
  • 9Dunn SE, Coombes AGA, Garnett MC,et al. In vitro cell interaction and in vivo biodistribution of poly (lactide-coglycolide) nanospheres surface modified by poloxamer and poloxamine copolymers [J]. J Controlled Release, 1997,44(1):65-71.
  • 10Boisdron-Celle M, Menei P, Benoit JP.Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers [J]. J Pharm Pharmacol, 1995,47(2):108-114.

共引文献63

同被引文献40

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部